XML 23 R33.htm IDEA: XBRL DOCUMENT v3.2.0.727
Summary of Significant Accounting Policies - Additional Information (Detail) - Related Party [Domain] - Equity Component [Domain] - USD ($)
 1 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 13, 2014
Nov. 18, 2014
Oct. 30, 2014
Jul. 31, 2014
Mar. 28, 2014
Mar. 31, 2014
Dec. 31, 2014
Sep. 30, 2014
Mar. 31, 2015
Mar. 31, 2014
Jan. 31, 2014
Summary Of Significant Accounting Policies [Line Items]                      
Expected term 6 years 6 years 6 years 6 years 7 years   6 years        
Risk free interest rate 1.62% 1.47% 1.62% 1.63% 2.31%   1.62%        
Expected volatility rate 62.90% 62.10% 62.90% 63.70% 71.40%   62.90%        
Expected dividend rate 0.00% 0.00% 0.00% 0.00%     0.00%        
Share Price $ 3.90 $ 4.60 $ 4.30 $ 5.90     $ 3.90        
Health Care Organization, Patient Service Revenue                 $ 20,000    
non-controlling interest           $ 0     725,278   $ 0
Financial Liabilities Fair Value Disclosure                 2,586,854    
Depreciation and Amortization Expense           516     $ 207,063   25,388
Percentage of Interest Rate for Certificates                 0.15%    
Gain (Loss) on Derivative Instruments, Net, Pretax           0     $ 833,545   0
Deferred Finance Costs, Current, Net           0     513,646 $ 0 97,806
Restricted Cash and Investments, Current, Total           20,000     530,000 20,000 20,000
Deferred Tax Liabilities, Net           4,954     171,215 $ 4,954 0
Deferred Income Tax Expense (Benefit)           $ 4,954     $ (51,922)   $ 0
Convertible Notes Payable [Member]                      
Summary Of Significant Accounting Policies [Line Items]                      
Debt Instrument, Interest Rate, Stated Percentage         8.00%            
Debt Instrument, Convertible, Conversion Price         $ 10.00            
2014 NNA Financing                      
Summary Of Significant Accounting Policies [Line Items]                      
Expected term                 6 years 7 years  
Risk free interest rate                 1.53% 2.31%  
Expected volatility rate                 57.40% 71.40%  
Expected dividend rate                 0.00% 0.00%  
Share Price           $ 4.50     $ 5.00 $ 4.50  
Percentage For Down round financing                 100.00% 50.00%  
Financial Liabilities Fair Value Disclosure           $ 2,354,624     $ 2,144,496 $ 2,354,624  
2014 NNA Financing 8% Convertible Note                      
Summary Of Significant Accounting Policies [Line Items]                      
Expected term                 4 years    
Risk free interest rate                 1.10%    
Expected volatility rate                 47.60%    
Expected dividend rate                 0.00%    
Share Price                 $ 5.00    
Percentage For Down round financing                 100.00%    
Debt Instrument, Interest Rate, Stated Percentage                 8.00%    
Debt Instrument, Convertible, Conversion Price                 $ 10.00    
Financial Liabilities Fair Value Disclosure                 $ 442,358    
Maximum                      
Summary Of Significant Accounting Policies [Line Items]                      
Management agreement, initial term                 20 years    
Minimum                      
Summary Of Significant Accounting Policies [Line Items]                      
Management agreement, initial term                 10 years    
Computer and Software                      
Summary Of Significant Accounting Policies [Line Items]                      
Property, Plant and Equipment, Useful Life                 3 years    
Furniture and fixtures                      
Summary Of Significant Accounting Policies [Line Items]                      
Property, Plant and Equipment, Useful Life                 8 years    
Machinery and Equipment                      
Summary Of Significant Accounting Policies [Line Items]                      
Property, Plant and Equipment, Useful Life                 5 years    
ApolloMed ACO                      
Summary Of Significant Accounting Policies [Line Items]                      
Health Care Organization, Patient Service Revenue               $ 10,980,000 $ 5,380,000